망막 레이저 광응고술 시장 규모, 점유율, 동향 분석 리포트 : 레이저 유형별, 적응증별, 모달리티별, 최종 용도별, 지역별, 부문 예측(2024-2030년)

Retinal Laser Photocoagulation Market Growth & Trends:

The global retinal laser photocoagulation market size is expected to reach USD 322.7 million by 2030, registering a CAGR of 4.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Laser technology advancements have improved this treatment's precision and effectiveness, reducing side effects and improving patient outcomes. The minimally invasive procedure makes it a preferred option for patients and healthcare providers, as it involves less discomfort and shorter recovery times than traditional surgical methods. The prevalence of vision-threatening diabetic retinopathy (VTDR) in people with diabetes aged 40 years or older in India highlights a critical need for effective treatments like retinal laser photocoagulation.

According to the Lancet Global Health in December 2022, with at least 3 million people at risk or already experiencing vision loss due to VTDR, there is an urgent demand for accessible and efficient medical interventions. This significant burden underscores the necessity for healthcare policies and strategies that prioritize early identification and treatment of VTDR. Recognizing VTDR's varying impact across India is crucial for targeted screening and treatment programs. Policymakers can create systematic approaches to manage diabetic retinopathy, focusing resources where most needed. Integrating retinal laser photocoagulation into these strategies meets the demand for effective treatments, improving patient outcomes. Heightened awareness of VTDR can prompt investments in healthcare infrastructure and training, expanding capacity for these services. This can foster market growth as more patients access timely treatment, mitigating VTDR's overall impact on the population.

Retinal Laser Photocoagulation Market Report Highlights:

• Based on the laser type, the green laser segment accounted for the largest revenue share of 44.3% in 2023 due to its high absorption by hemoglobin and melanin, enhancing precision in targeting retinal tissue
• The yellow laser segment is expected to grow at the fastest CAGR of 4.5% from 2024 to 2030 due to its superior absorption by oxygenated and deoxygenated hemoglobin. This results in improved treatment efficacy and reduces collateral damage
• Based on the indication, the proliferative diabetic retinopathy (PDR) segment accounted for the largest revenue share of 29.7% in 2023 due to its effectiveness in reducing vision loss by sealing leaking blood vessels and reducing abnormal neovascularization. This targeted treatment improves patient outcomes and slows disease progression, making it a crucial intervention in PDR management
• The retinal tears segment is expected to grow at the fastest CAGR of 4.7% from 2024 to 2030 due to its ability to create a strong adhesion around the tear, preventing retinal detachment
• Based on the modality, the fixed segment accounted for the largest revenue share of 71.8% in 2023 and is expected to grow at the fastest CAGR of 4.6% from 2024 to 2030 driven by their stability and precision, which ensure consistent treatment outcomes. These systems are essential in clinical settings, providing reliable performance for managing various retinal conditions
• Based on the end use, the hospitals segment accounted for the largest revenue share of 54.7% in 2023. On the other hand, the ambulatory surgical centers (ASCs) segment is expected to grow at the fastest CAGR of 4.8% from 2024 to 2030
• North America dominated the global market in 2023 with a revenue share of 32.9% due to the presence of advanced healthcare infrastructure, a rise in retinal disease cases, and significant healthcare expenditure in the region

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Laser Type
  • 1.2.2. Indication
  • 1.2.3. Modality
  • 1.2.4. End Use
  • 1.2.5. Regional scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Laser type outlook
  • 2.2.2. Indication outlook
  • 2.2.3. Modality outlook
  • 2.2.4. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Retinal Laser Photocoagulation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of retinal disorders
    • 3.2.1.2. Advancements in imaging systems
    • 3.2.1.3. Growing emphasis on regular eye examinations
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Specialized Equipment
    • 3.2.2.2. Potential Risks and Complications
    • 3.2.2.3. Variability in Reimbursement Policies
• 3.3. Retinal Laser Photocoagulation Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Retinal Laser Photocoagulation Market: Laser Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Retinal Laser Photocoagulation Market: Laser Type Movement Analysis
• 4.3. Retinal Laser Photocoagulation Market by Laser Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Diode laser
  • 4.5.1. Diode Laser Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Green laser
  • 4.6.1. Green Laser Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Yellow laser
  • 4.7.1. Yellow Laser Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Retinal Laser Photocoagulation Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Retinal Laser Photocoagulation Market: Indication Movement Analysis
• 5.3. Retinal Laser Photocoagulation Market by Indication Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Proliferative Diabetic Retinopathy (PDR)
  • 5.5.1. Proliferative Diabetic Retinopathy (PDR) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Diabetic Macular Edema
  • 5.6.1. Diabetic Macular Edema Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Retinal Vein Occlusion
  • 5.7.1. Retinal Vein Occlusion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Retinal Tears
  • 5.8.1. Retinal Tears Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Retinal Laser Photocoagulation Market: Modality Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Retinal Laser Photocoagulation Market: Modality Movement Analysis
• 6.3. Retinal laser photocoagulation Market by Modality Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Fixed
  • 6.5.1. Fixed Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Mobile
  • 6.6.1. Mobile Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Retinal Laser Photocoagulation Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Retinal Laser Photocoagulation Market: End Use Movement Analysis
• 7.3. Retinal Laser Photocoagulation Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Hospitals
  • 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Ambulatory Surgical Centers
  • 7.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Ophthalmic Clinics
  • 7.7.1. Ophthalmic Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Retinal Laser Photocoagulation Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Regional Retinal Laser Photocoagulation Market movement analysis
• 8.3. Retinal Laser Photocoagulation Market: Regional Estimates & Trend Analysis by Technology & End Use
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. North America
  • 8.5.1. North America Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. Reimbursement scenario
    • 8.5.2.5. U.S. Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Reimbursement scenario
    • 8.5.3.5. Canada Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Reimbursement scenario
    • 8.5.4.5. Mexico Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Europe
  • 8.5.6. Europe Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. UK
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Reimbursement scenario
    • 8.5.7.5. UK Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Germany
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Reimbursement scenario
    • 8.5.8.5. Germany Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. France
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Reimbursement scenario
    • 8.5.9.5. France Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.10. Italy
    • 8.5.10.1. Key Country Dynamics
    • 8.5.10.2. Competitive Scenario
    • 8.5.10.3. Regulatory Framework
    • 8.5.10.4. Reimbursement scenario
    • 8.5.10.5. Italy Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.11. Spain
    • 8.5.11.1. Key Country Dynamics
    • 8.5.11.2. Competitive Scenario
    • 8.5.11.3. Regulatory Framework
    • 8.5.11.4. Reimbursement scenario
    • 8.5.11.5. Spain Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.12. Denmark
    • 8.5.12.1. Key Country Dynamics
    • 8.5.12.2. Competitive Scenario
    • 8.5.12.3. Regulatory Framework
    • 8.5.12.4. Reimbursement scenario
    • 8.5.12.5. Denmark Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.13. Sweden
    • 8.5.13.1. Key Country Dynamics
    • 8.5.13.2. Competitive Scenario
    • 8.5.13.3. Regulatory Framework
    • 8.5.13.4. Reimbursement scenario
    • 8.5.13.5. Sweden Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.14. Norway
    • 8.5.14.1. Key Country Dynamics
    • 8.5.14.2. Competitive Scenario
    • 8.5.14.3. Regulatory Framework
    • 8.5.14.4. Reimbursement scenario
    • 8.5.14.5. Norway Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Reimbursement scenario
    • 8.6.2.5. Japan Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Reimbursement scenario
    • 8.6.3.5. China Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. Reimbursement scenario
    • 8.6.4.5. India Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. South Korea
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Reimbursement scenario
    • 8.6.5.5. South Korea Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. Australia
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Reimbursement scenario
    • 8.6.6.5. Australia Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Reimbursement scenario
    • 8.6.7.5. Thailand Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Reimbursement scenario
    • 8.7.2.5. Brazil Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Reimbursement scenario
    • 8.7.3.5. Argentina Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. Reimbursement scenario
    • 8.8.2.5. South Africa Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Reimbursement scenario
    • 8.8.3.5. Saudi Arabia Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. Reimbursement scenario
    • 8.8.4.5. UAE Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Reimbursement scenario
    • 8.8.5.5. Kuwait Retinal Laser Photocoagulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Alcon, Inc.
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. Carl Zeiss
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Quantel Medical
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. Lumenis
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. IRIDEX Corporation
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. NIDEK CO., LTD.
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. TOPCON CORPORATION
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Bausch & Lomb Incorporated
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Meridian Medical Group
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives